HOME  >  会社情報  >  会社概要・沿革

about us

about us

Company name
TOKIWA Pharmaceutical Co., Ltd.
Midousuji Azuchimachi Bldg.9F, 3-5-12 Azuchi-machi,
Chuo-ku, Osaka, Japan
Date of Incorporation
February, 1954
4,301,265 thousand Japanese Yen
Noevir Holdings Co., Ltd.
President and Representative Director
Masataka Nakano
No.Of Employees
As of September 30, 2015
Non-consolidated : 397
Consolidated : 810
Lines of Business
Tokiwa develops, manufactures and markets pharmaceuticals, quasi-drugs, cosmetics and health food products.
[Headquarters] Tokyo, Osaka and Kobe
[Location of Offices] Sapporo, Sendai, Tokyo, Nagoya, Osaka, Hiroshima, and Fukuoka.
[Location of Factory] Mie
Affiliated company
Noevir Holdings Co., Ltd.
Noevir Co., Ltd.
Bonanza Co., Ltd.
Tokiwa Medical Service Co., Ltd.


February, 1954
Incorporated TOKIWA Pharmaceutical Co.,Ltd.
September, 2002
Tokiwa Pharmaceutical became a subsidiary of Noevir Co., Ltd.
September, 2004
Three subsidiary companies, Tokiwa Pharmaceutical, NOV and SANA,
under Noevir Co., Ltd. merged as part of its subsidiary reorganization
June, 2011
Tokiwa Pharmaceutical was transferred to become a subsidiary of Noevir Holdings Co., Ltd. from Noevir Co., Ltd. in reorganization.